
Anumana builds AI algorithms that analyze electrical cardiac signals to enable earlier detection and clinical decision support for cardiovascular disease. The company develops ECG-AI and EGM-AI models using large electrophysiological and patient-history datasets and translational-science methods to produce investigational medical-device software. Its solutions are designed to integrate into clinical workflows and support perioperative, acute, and ambulatory cardiology settings. Anumana emphasizes peer-reviewed validation and FDA-ready algorithm development to support adoption by healthcare providers and institutions.

Anumana builds AI algorithms that analyze electrical cardiac signals to enable earlier detection and clinical decision support for cardiovascular disease. The company develops ECG-AI and EGM-AI models using large electrophysiological and patient-history datasets and translational-science methods to produce investigational medical-device software. Its solutions are designed to integrate into clinical workflows and support perioperative, acute, and ambulatory cardiology settings. Anumana emphasizes peer-reviewed validation and FDA-ready algorithm development to support adoption by healthcare providers and institutions.